Advanced Malignant Solid Tumor
33
15
17
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
6.1%
2 terminated out of 33 trials
0.0%
-86.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (33)
PRL3-Zumab in Patients With Advanced Solid Tumors
A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function
A Study of MHB009C in Patients With Advanced Solid Tumors
A Study of MHB048C in Patients With Advanced Solid Tumors
A Study of MHB042C in Patients With Advanced Solid Tumors
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors
Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden
A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors
A Study of JSKN027 in Patients With Advanced Solid Tumors
Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors
A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer
Phase I/II Study of SCTB39G in Advanced Solid Tumours
Phase I/II Study of SCTB39-1 in Advanced Solid Tumours
A Study of MHB118C Injection in Patients With Advanced Solid Tumors
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors
Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors